[Profound mycoses in AIDS in Abidjan (Côte d'Ivoire)]. 1997

S P Eholie, and L N'gbocho, and E Bissagnene, and M Coulibaly, and E Ehui, and O Kra, and A Assoumou, and E Aoussi, and A Kadio
Service de maladies infectieuses et tropicales, CHU de Treichville, Abidjan, Côte d'Ivoire.

During 1995, among 1105 HIV patients explored in our department, 64 presented a deep fungic infection (5.8%). The yeast was searched for in cerebrospinal fluid, blood, urine, and bronchoalveolar aspiration. Isolated germs were Cryptococcus neoformans (95%), Candida tropicalis (1 case), Saccharomyces cerevisiae (1 case) et Aspergillus fumigatus (1 case). Results of treatment with amphotericin B were: recovery (9%), clinical success (11%), out of sight (14%), letality (66%), relapse (23%) and side effects (19%). We emphasized diagnostical and therapeutical difficulties, and bad prognostic of mycoses in patients with AIDS.

UI MeSH Term Description Entries
D007560 Cote d'Ivoire A republic in western Africa, south of MALI and BURKINA FASO, bordered by GHANA on the east. Its administrative capital is Abidjan and Yamoussoukro has been the official capital since 1983. The country was formerly called Ivory Coast. Ivory Coast,Republic of Cote diIvoire
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001826 Body Fluids Liquid components of living organisms. Body Fluid,Fluid, Body,Fluids, Body
D002175 Candida A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; VULVOVAGINAL CANDIDIASIS; and CANDIDIASIS, ORAL (THRUSH). Candida guilliermondii var. nitratophila,Candida utilis,Cyberlindnera jadinii,Hansenula jadinii,Lindnera jadinii,Monilia,Pichia jadinii,Saccharomyces jadinii,Torula utilis,Torulopsis utilis,Monilias
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D003453 Cryptococcosis Fungal infection caused by genus CRYPTOCOCCUS. C gattii Infection,C neoformans Infection,C. gattii Infection,C. neoformans Infection,Cryptococcus Infection,Cryptococcus Infections,Cryptococcus gattii Infection,Torulosis,Cryptococcus neoformans Infection,C gattii Infections,C neoformans Infections,C. gattii Infections,C. neoformans Infections,Cryptococcoses,Cryptococcus gattii Infections,Cryptococcus neoformans Infections,Infection, C gattii,Infection, C neoformans,Infection, C. gattii,Infection, C. neoformans,Infection, Cryptococcus,Infection, Cryptococcus gattii,Infection, Cryptococcus neoformans,Infections, C gattii,Infections, C. neoformans,Toruloses
D003455 Cryptococcus neoformans A species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella neoformans. Blastomyces neoformans,Debaryomyces neoformans,Filobasidiella neoformans,Lipomyces neoformans,Saccharomyces neoformans,Torula neoformans,Torulopsis neoformans,Cryptococcus neoformans var. grubii
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency

Related Publications

S P Eholie, and L N'gbocho, and E Bissagnene, and M Coulibaly, and E Ehui, and O Kra, and A Assoumou, and E Aoussi, and A Kadio
August 1989, AIDS (London, England),
S P Eholie, and L N'gbocho, and E Bissagnene, and M Coulibaly, and E Ehui, and O Kra, and A Assoumou, and E Aoussi, and A Kadio
January 1993, AIDS care,
S P Eholie, and L N'gbocho, and E Bissagnene, and M Coulibaly, and E Ehui, and O Kra, and A Assoumou, and E Aoussi, and A Kadio
January 2012, Medecine et sante tropicales,
S P Eholie, and L N'gbocho, and E Bissagnene, and M Coulibaly, and E Ehui, and O Kra, and A Assoumou, and E Aoussi, and A Kadio
April 1991, AIDS (London, England),
S P Eholie, and L N'gbocho, and E Bissagnene, and M Coulibaly, and E Ehui, and O Kra, and A Assoumou, and E Aoussi, and A Kadio
July 2022, Journal of public health in Africa,
S P Eholie, and L N'gbocho, and E Bissagnene, and M Coulibaly, and E Ehui, and O Kra, and A Assoumou, and E Aoussi, and A Kadio
June 2006, Toxicon : official journal of the International Society on Toxinology,
S P Eholie, and L N'gbocho, and E Bissagnene, and M Coulibaly, and E Ehui, and O Kra, and A Assoumou, and E Aoussi, and A Kadio
January 2004, Bulletin de la Societe de pathologie exotique (1990),
S P Eholie, and L N'gbocho, and E Bissagnene, and M Coulibaly, and E Ehui, and O Kra, and A Assoumou, and E Aoussi, and A Kadio
October 2008, Bulletin de la Societe de pathologie exotique (1990),
S P Eholie, and L N'gbocho, and E Bissagnene, and M Coulibaly, and E Ehui, and O Kra, and A Assoumou, and E Aoussi, and A Kadio
February 2000, Bulletin de la Societe de pathologie exotique (1990),
S P Eholie, and L N'gbocho, and E Bissagnene, and M Coulibaly, and E Ehui, and O Kra, and A Assoumou, and E Aoussi, and A Kadio
December 2023, Human vaccines & immunotherapeutics,
Copied contents to your clipboard!